Ozempic (semaglutide) and WeGovy (semaglutide) also work by mimicking the action of GLP-1, but it has a longer half-life, allowing for once-weekly dosing
The recommended dosage may vary depending on individual patient characteristics and treatment goals
It has also been shown to protect against heart attacks, strokes, and death in people with diabetes
Refrigeration at 2 to 8 degrees Celsius remains the recommended storage method after reconstitution
In October 2023, the Journal of the American Medical Association examined adverse events associated with GLP-1 receptor agonists prescribed for weight loss, and researchers concluded that using the drugs increases the risk of gastrointestinal adverse effects, such as biliary disease, pancreatitis, bowel obstruction, and stomach paralysis
Legalization vs